RPA2 and glioma: We found that Method B produced a simpler classifier made up of only 6 genes with 2 in common CDK2 and “replication protein A2” (RPA2) with the 23 genes, and performed slightly less optimally to the 23-gene classifier in the eight glioma cohorts, but very poorly in the 12 other tumor cohorts.